Peel Hunt upgraded shares of Clinigen Group PLC (LON:CLIN) to a buy rating in a research report released on Tuesday. The firm currently has GBX 1,350 ($17.75) price objective on the stock, up from their prior price objective of GBX 1,200 ($15.78).
Separately, Numis Securities Ltd cut Clinigen Group PLC to an add rating and set a GBX 1,100 ($14.46) price objective for the company. in a report on Tuesday, July 18th.
Shares of Clinigen Group PLC (CLIN) opened at 1151.00 on Tuesday. Clinigen Group PLC has a 12 month low of GBX 695.00 and a 12 month high of GBX 1,175.00. The company’s 50 day moving average price is GBX 1,106.30 and its 200 day moving average price is GBX 946.10. The company’s market capitalization is GBX 1.32 billion.
Clinigen Group PLC (LON:CLIN) last posted its quarterly earnings data on Thursday, September 28th. The company reported GBX 41.80 ($0.55) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of GBX 41.20 ($0.54) by GBX 0.60 ($0.01). Clinigen Group PLC had a return on equity of 0.98% and a net margin of 0.70%. The firm had revenue of £302.30 million during the quarter.
ILLEGAL ACTIVITY NOTICE: “Clinigen Group PLC (CLIN) Lifted to Buy at Peel Hunt” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://www.tickerreport.com/banking-finance/2957119/clinigen-group-plc-clin-lifted-to-buy-at-peel-hunt.html.
The company also recently disclosed a dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be issued a GBX 3.40 ($0.04) dividend. This is a boost from Clinigen Group PLC’s previous dividend of $1.60. This represents a dividend yield of 0.32%. The ex-dividend date of this dividend is Thursday, November 9th.
In other news, insider John Bacon sold 250,000 shares of the business’s stock in a transaction dated Monday, October 2nd. The stock was sold at an average price of GBX 1,093 ($14.37), for a total value of £2,732,500 ($3,592,558.51).
About Clinigen Group PLC
Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.